Afolabi, A.,
Mustafina, I.,
Zhao, L.,
Li, L.,
Sun, R.,
Hu, S.,
Zhang, S.,
Jia, H.,
Guilio, G.,
Yu, B. (2018) of plaque progression to statin
therapy. Background: Previous studies showed that the presence of spotty
NIKITIN, A.G.,
CHUDAKOVA, D.A.,
ENIKEEV, R.F.,
GORDIEV, M.G.,
SAKAEVA, D.,
DRUZHKOV, M.,
SHIGAPOVA, L.H.,
BROVKINA, O.I.,
SHAGIMARDANOVA, E.I.,
GUSEV, O.A. (2020) (BC). In this study, we performed
Targeted Next-Generation Sequencing of MMR pathway genes MLH1, MSH2
Gilyazova, I.,
Ivanova, E.,
Pavlov, V.,
Khasanova, G.,
Khasanova, A.,
Izmailov, A.,
Asadullina, D.,
Gilyazova, G.,
Wang, G.,
Gareev, I.,
Beylerli, O. (2023) RNAs and the network of genes that can
be potential
targets for the studied miRNAs in order to elucidate the molecular
Nasyrova, Regina F.,
Khasanova, Aiperi K.,
Altynbekov, Kuanysh S.,
Asadullin, Azat R.,
Markina, Ekaterina A.,
Gayduk, Arseny J.,
Shipulin, German A.,
Petrova, Marina M.,
Shnayder, Natalia A. (2022) the search for new therapeutic strategies for a disease-modifying
therapy for treatment-resistant Sch (TRS
basis for a specific
targeted effect on reversible epigenetic mechanisms of their origin. Non
, therapeutic approaches that
target both diseases are needed. Clinical trials are currently underway to explore